Page last updated: 2024-10-28

guaifenesin and Marfan Syndrome

guaifenesin has been researched along with Marfan Syndrome in 2 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, WM1
Matloff, JM1
Fishbein, MC1
Aslam, PA1
Eastridge, CE1
Bernhardt, H1
Pate, JW1

Other Studies

2 other studies available for guaifenesin and Marfan Syndrome

ArticleYear
Myxoid degeneration of the aortic valve and isolated severe aortic regurgitation.
    The American journal of cardiology, 1985, Feb-01, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Aged; Aortic Aneurysm; Aortic Valve; Aortic Valve Insufficiency; Endocarditis, Ba

1985
Myxomatous degeneration of cardiac valves.
    Chest, 1970, Volume: 57, Issue:6

    Topics: Adult; Aged; Aortic Valve; Aortic Valve Insufficiency; Female; Heart Valve Diseases; Humans; Male; M

1970